Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.
Biotechnology
US, Chicago [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Cardio Diagnostics Holdings, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCardio Diagnostics Holdings, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Cardio Diagnostics Holdings, Inc..
If you want to see a demo, head over to the financial segments of AAPL